skip to content

Cambridge Immunology Network

 
Read more at: Unexpected experiences: Mike Weekes describes setting up a full-scale COVID-19 testing facility

Unexpected experiences: Mike Weekes describes setting up a full-scale COVID-19 testing facility

27 August 2020

When infectious diseases expert Mike Weekes realised he and colleagues had the know-how to help protect staff, patients and students in a pandemic, they set up a unique testing facility – the first of its kind, they believe, in a UK university – and now a central part of a new public health campaign, Stay Safe Cambridge...


Read more at: Cambridge-developed SARS-CoV-2 vaccine receives £1.9million from UK government for clinical trial

Cambridge-developed SARS-CoV-2 vaccine receives £1.9million from UK government for clinical trial

26 August 2020

A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9million award from the UK government. Innovate UK, the UK government’s innovation agency, has provided the funding for a collaboration between Cambridge spin-out company...


Read more at: Tackling COVID-19: Professor Daniela De Angelis

Tackling COVID-19: Professor Daniela De Angelis

21 August 2020

Since January this year, Daniela De Angelis and her team have been informing the UK Government’s response to the COVID-19 pandemic. Their real-time model of transmission of the virus is helping to track and predict its course as information accumulates over time. Read the original article here>


Read more at: Ageing heart cells offer clues to susceptibility of older people to severe COVID-19

Ageing heart cells offer clues to susceptibility of older people to severe COVID-19

18 August 2020

Genes that play an important role in allowing SARS-CoV-2 to invade heart cells become more active with age, according to research published today in the Journal of Molecular and Cellular Cardiology . Read the original article here>


Read more at: Professor Gordon Dougan receives Albert B Sabin Gold Medal Award for work in vaccinology

Professor Gordon Dougan receives Albert B Sabin Gold Medal Award for work in vaccinology

13 August 2020

Professor Gordon Dougan has been awarded this year’s Albert B Sabin Gold Medal Award for his work in vaccinology. Awarded annually by the Albert B Sabin Institute in Washington and named after the inventor of the oral polio vaccine, the medal is the highest international award for contributions to vaccinology and disease...


Read more at: Cambridge academics elected to British Academy fellowship

Cambridge academics elected to British Academy fellowship

27 July 2020

Eight academics from the University of Cambridge have been made Fellows of the prestigious British Academy for the humanities and social sciences. They are among 86 distinguished scholars to be elected to the fellowship in recognition of their work in the fields of law, economics, Middle Eastern studies, geography, history...


Read more at: Rapid genome sequencing and screening help hospital manage COVID-19 outbreaks

Rapid genome sequencing and screening help hospital manage COVID-19 outbreaks

14 July 2020

Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections. Since the start of the UK pandemic, when the virus was spreading between people, a team of scientists and clinicians at the...


Read more at: Tackling COVID-19: Dr Estée Török

Tackling COVID-19: Dr Estée Török

9 July 2020

Long hours running COVID-19 vaccine and drugs trials have left little time for Estée Török to contemplate her postponed wedding. With over twenty years' clinical research experience in infectious diseases in the UK and south-east Asia, she has a great deal to contribute to tackling the pandemic. Read the original article...


Read more at: Rapid coronavirus test speeds up access to urgent care and will free up beds ahead of winter

Rapid coronavirus test speeds up access to urgent care and will free up beds ahead of winter

3 June 2020

The first analysis of a new point-of-care 'nucleic acid test' for SARS-CoV-2 in a UK hospital setting shows these machines dramatically reduce time spent on COVID-19 ‘holding’ wards – allowing patients to be treated or discharged far quicker than with current lab testing set-ups. Read original article here>


Read more at: The Academy of Medical Sciences announces new Fellows for 2020

The Academy of Medical Sciences announces new Fellows for 2020

13 May 2020

Six affiliates of the University of Cambridge are among 50 world-leading UK researchers who have been elected to the prestigious Fellowship of the Academy of Medical Sciences. The new Fellows have been chosen for their exceptional contributions to advancing biomedical science via world-leading research discoveries, running...